01

02

03

[1] What's next for AlphaFold and the AI protein-folding revolution，Retrieved Dec 16th，2022，from https://www.nature.com/articles/d41586-022-00997-5

[2] Alphabet’s AI predicted the structure of 200 million proteins. Can it really speed up drug discovery?  Retrieved Dec 16th，2022，from https://www.statnews.com/2022/10/13/can-alphabet-alphafold-really-speed-up-drug-discovery/

[3] What does AlphaFold mean for drug discovery? Retrieved Dec 16th，2022， from http://nmg.wor1dbwvwvvrrnm.top/rwt/30/https/P75YPLUPMF4HK6UFF3SX85B/articles/d41573-021-00161-0

[4] AlphaFold’s new rival? Meta AI predicts shape of 600 million proteins，Retrieved Dec 16th，2022， from https://www.nature.com/articles/d41586-022-03539-1

[5] Scientists are finally learning how to design proteins from scratch. Drug development may never be the same. Retrieved Dec 16th, 2022，from https://endpts.com/scientists-are-finally-learning-how-to-design-proteins-from-scratch-drug-development-may-never-be-the-same/

[6] Generate Biomedicines Uses AI to Create Proteins That Have Never Existed. Retrieved December 16th, 2022, from https://www.businesswire.com/news/home/20221201005267/en/Generate-Biomedicines-Uses-AI-to-Create-Proteins-That-Have-Never-Existed

[7] David Baker’s lab and ARCH sprout Lord of the Rings-inspired macrocycle biotech. Retrieved Dec 16th , 2022, from https://endpts.com/david-bakers-lab-and-arch-sprout-lord-of-the-rings-inspired-macrocycle-biotech/

[8] Bhardwaj et al., (2022). Accurate de novo design of membrane-traversing macrocycles. Cell, https://doi.org/10.1016/j.cell.2022.07.019

[9] Vilya Launches to Design a New Transformational Class of Medicines That Precisely Target Disease Biology，Retrieved Dec 16th , 2022, from https://www.businesswire.com/news/home/20220829005088/en/Vilya-Launches-to-Design-a-New-Transformational-Class-of-Medicines-That-Precisely-Target-Disease-Biology

[10] AI is helping Matthew Higgins and his team develop a vaccine that could dismantle the malaria parasite’s ability to infect humans, potentially saving hundreds of thousands of lives every year，Retrieved Dec 16th from https://unfolded.deepmind.com/stories/matthew-higgins-is-unlocking-a-new-path-to-stop-malaria-in-its-tracks

[11] Gupta, Meghna et al. “CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.” bioRxiv : the preprint server for biology 2021.05.10.443524. 11 May. 2021, doi:10.1101/2021.05.10.443524. Preprint. Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201，Retrieved Dec 16th from https://investors.beamtx.com/news-releases/news-release-details/beam-therapeutics-announces-fda-has-lifted-clinical-hold

[12] Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing. Retrieved Dec 16th , 2022, from https://www.prnewswire.com/news-releases/prime-medicine-launches-with-315-million-financing-to-deliver-on-the-promise-of-prime-editing-301332085.html

[13] Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases. Retrieved Dec 16th, 2022, from https://investors.apellis.com/news-releases/news-release-details/apellis-and-beam-therapeutics-enter-exclusive-research

[14] Base editing: Revolutionary therapy clears girl's incurable cancer. Retrieved Dec 16th, 2022, from https://www.bbc.com/news/health-63859184 

[15] Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the Central Nervous System and Peripheral Organs with Low Affinity for the Liver, . Retrieved Dec 16th, 2022, from https://homologymedicines.com/news-story/homology-medicines-announces-peer-reviewed-publication-on-novel-discovery-of-aavhsc-with-robust-distribution-to-the-central-nervous-system-and-peripheral-organs-with-low-affinity-for-the-liver

[16] Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs. Retrieved Dec 16th, 2022, from https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-announces-license-option-agreement-novartis

[17] Voyager Therapeutics Announces Pfizer License of Next-Generation AAV Capsid for Rare Neurologic Disease Target. Retrieved Dec 16th, 2022, from https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-announces-pfizer-license-next-generation

[18] Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline. Retrieved Dec 16th, 2022, from  https://www.businesswire.com/news/home/20220621005289/en

[19] Mustang Bio Announces a Phase 1 Clinical Trial Combining MB-101 (IL13Rα2‐targeted CAR T cell therapy) and MB-108 (C134 oncolytic virus) for the Treatment of Glioblastoma. Retrieved Dec 16th, 2022, from https://ir.mustangbio.com/news-events/press-releases/detail/137/mustang-bio-announces-a-phase-1-clinical-trial-combining

[20] 码刻 | 「星锐医药」宣布完成1.5亿元A轮融资 源码参投. Retrieved Dec 16th, 2022, from https://mp.weixin.qq.com/s/W1EYNvDuBwu-1FWN5E186Q

[21] ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M. . Retrieved Dec 16th, 2022, from https://www.businesswire.com/news/home/20220629005119/en

[22] Versant Ventures Launches Vector BioPharma AG. . Retrieved Dec 16th, 2022, from https://www.businesswire.com/news/home/20220810005124/en/Versant-Ventures-Launches-Vector-BioPharma-AG

[23] Targeting gene therapy directly into the lungs. Retrieved Dec 16th, 2022, from https://medicalxpress.com/news/2022-02-gene-therapy-lungs.html

[24] SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development. Retrieved Dec 16th, 2022, from https://www.businesswire.com/news/home/20221205005008/en/SonoThera%E2%84%A2-Completes-60.75M-Series-A-Funding-for-Ultrasound-Guided-Nonviral-Gene-Therapy-Platform-Development